InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-36.5%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Bohlin Garen G, Director. Director active across 3 companies, notably Collegium Pharmaceutical, INC. Aggregated, 9 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €72k. History available since 6 May 2021. The latest transaction was disclosed on 21 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bohlin Garen G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
15,508 股0Common StockSEC:0001254705-26-000008:0
8,700 股@ US$16.490.0083% mcap100.0% 占其流量Common StockSEC:0001254705-26-000002:0
9,791 股0Common StockSEC:0001062993-25-009808:0
28,985 股@ US$5.7355.8% 占其流量Common StockSEC:0001062993-24-010536:0
41,140 股@ US$1.21547.3% 占其流量Common StockSEC:0000950170-23-047712:0
标准退出：2023年12月11日 (T+90)
9,792 股0Common StockSEC:0001062993-23-011813:0
14,035 股0Common StockSEC:0001062993-22-013300:0
9,941 股0Common StockSEC:0001192482-21-000453:0
4,000 股@ US$7.8235.8% 占其流量Common StockSEC:0001209191-21-031437:0
标准退出：2021年8月4日 (T+90)
9 条申报中的 9 条
About Bohlin Garen G
BOHLIN GAREN G is a Board Member at COLLEGIUM PHARMACEUTICAL, INC and Karyopharm Therapeutics Inc. He contributes to the governance and strategy of the companies, bringing his expertise in leadership and decision-making.
